Abstract:Non-structural protein (NSP) 3ABC antibody is considered to be the most reliable indicator of present or past infection with foot-and-mouth disease virus (FMDV) in vaccinated animals. An indirect ELISA was established, using purified His-tagged 3ABC fusion protein as antigen, for detection of the antibody response to FMDV NSP 3ABC in different animal species. The method was validated by simultaneous detection of the early antibody responses to NSP and structural protein (SP) in FMDV Asia 1 infected animals. The performance of the method was also validated by detection of antibody in reference sera from the FMD World Reference Laboratory (WRL) in Pirbright, UK, and comparison with two commercial NSP ELISA kits. The results showed that the antibody response to SP developed more quickly than that to NSP 3ABC in FMDV infected animals. In contact-infected cattle, the antibody response to NSP 3ABC was significantly delayed compared with that to SP antibody. The early antibody responses to SP and NSP 3ABC in FMDV inoculated cattle and contact-infected or inoculated sheep and pigs were generally consistent. In pigs, 3ABC antibody was linked to the presence of clinical signs; however, in sheep, subclinical infection was detected by the development of 3ABC antibodies. Therefore, the antibody responses to 3ABC varied between host species. Eight out of 10 positive serum samples from FMD WRL were tested to be positive at cutoff value of 0.2. The rate of agreement with the ceditest® FMDV-NS and the UBI® NSP ELISA were 98.05% (302/308) and 93.2% (287/308), respectively. The prevalence of 3ABC antibodies reached 71.4% in some diseased cattle herds. The further work is required to evaluation the performance of this method in different animal species and different field situations.

Preparation and Identification of Monoclonal Antibody Against Nonstructural Protein 3D of Foot-and-mouth Disease Virus

Preparation of Monoclonal Antibodies Against Nonstructural Protein 3AB of Foot-and-mouth Disease Virus and Analysis of Their Antigenic Epitope Domains

Development Of A Blocking Elisa Based On A Monoclonal Antibody Against A Predominant Epitope In Non-Structural Protein 3b2 Of Foot-And-Mouth Disease Virus For Differentiating Infected From Vaccinated Animals

Development and Validation of a 3ABC Indirect ELISA for Differentiation of Foot-and-mouth Disease Virus Infected from Vaccinated Animals

Production and Characterization of Monoclonal Antibodies Against Asia1 Foot-and-mouth Disease Virus

The Efficacy of FMD Vaccine Reduced Non-Structural Proteins with a Mab Against 3B Protein

Development and Characterization of Monoclonal Antibodies Against VP1 Protein of O Type Foot-and-mouth Disease Virus

Expression of the Major Epitope Regions of 2C Integrated with the 3AB Non-Structural Protein of Foot-and-mouth Disease Virus and Its Potential for Differentiating Infected from Vaccinated Animals

Preparation of Monoclonal Antibody Against Foot and Mouth Disease Virus and Development of Monoclonal Antibody-based Antigen Capture ELISA

Development and validation of a prokaryotically expressed foot-and-mouth disease virus non-structural protein 2C'3AB-based immunochromatographic strip to differentiate between infected and vaccinated animals

Cloning, Prokaryotic Expression and Antigenicity Identification of Nonstructural Protein 3A of Foot - and - Mouth Disease Virus Serotype Asia1

Screening of Mimotopes for Non-structural Protein 3ABC of O Type Foot-and-mouth-disease Virus

Cloning and Expression of the Nonstructural Protein 3B Gene of Foot-and Mouth Disease Virus and Development of 3B-ELISA for Differential Diagnosis

Preparation of Monoclonal Antibodies Against VP2 Protein of Asia Ⅰ Type Foot-and-mouth Disease Virus and Establishment of a Competitive ELISA for the Detection of Antibodies

Develope monoclonal antibody against foot-and-mouth disease virus A type

Evaluation of a 3A-Truncated Foot-and-mouth Disease Virus in Pigs for Its Potential As a Marker Vaccine

Development of a dot immunoblot method for differentiation of animals infected with foot-and-mouth disease virus from vaccinated animals using non-structural proteins expressed prokaryotically.

Construction and Characterization of 3A-Epitope-tagged Foot-And-Mouth Disease Virus

Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, As a Matching Test for a Negative-Marker Vaccine

Construction and Identification of Recombinant Adenovirus Expression VP1 of Foot and Mouth Disease Virus

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity